Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Spanish reimbursement system

- PMLiVE

J&J therapy for suicidal depressives ‘a breakthrough’, says FDA

Status granted to esketamine after phase II PeRSERVERe trial

- PMLiVE

A rising tide

HBA Europe’s Claudia Graeve and Kathrin Schoenborn-Sobolewski on furthering women’s advancement in healthcare

- PMLiVE

Stada CEO departs ahead of proxy battle with activist investors

Hartmut Retzlaff cites health reasons amid rumours of a company sale

- PMLiVE

Lupus trial hailed as a success despite patient deaths

Phase IIb trial of Aurinia Pharmaceuticals’ voclosporin met its objective

- PMLiVE

Going fully digital

Building a commercial content supply chain

Novartis day

Novartis plans major expansion of French antibody facility

Project aims to boost capacity by 70% and create new jobs

- PMLiVE

AstraZeneca adds cardiovascular resources to online diabetes programme

Expansion of Fit2Me also includes new Apple and Android mobile apps

- PMLiVE

Ireland’s Mallinckrodt buys US regenerative medicine firm

Stratatech’s StrataGraft in phase III testing for burns treatment

Deal Watch July 2016

Real deals, real money and - for some - reality bites

- PMLiVE

Cello Health appoints digital leaders in the US

Rick Lang and Craig Lipski join in senior roles

Why multichannel is not an in/out option

When it comes to multichannel communications, pharma cannot afford to maintain the status quo

Therapy Watch market snapshots

Therapy Watch is a ‘real-time’ syndicated market tracking tool that provides marketing teams, brand managers and market researchers with strategic and tactical market information. Run entirely online to ensure speed,...

Inizio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links